Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
June 11 2021 - 08:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of June 2021
Commission File Number: 001-37452
CELYAD ONCOLOGY SA
(Translation of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Celyad Oncology SA
On June 11, 2021, Celyad Oncology SA (the Company) issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is
incorporated by reference herein.
The Company will be presenting a poster presentation at the European Hematology Association Virtual Congress 2021 on
June 11, 2021. Following the release of the poster presentation, the Company will deliver the slide presentation furnished to this report as Exhibit 99.2 and which is incorporated herein by reference.
The information contained in this Current Report on Form 6-K, including Exhibit 99.1 and 99.2, except for the
quotes of Filippo Petti and Sébastien Anguille contained in Exhibit 99.1, is hereby incorporated by reference into the Companys Registration Statements on Form F-3 (File No. 333-248464) and Form S-8 (File No. 333-220737).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD ONCOLOGY SA
|
|
|
|
|
Date: June 11, 2021
|
|
|
|
By:
|
|
/s/ Filippo Petti
|
|
|
|
|
|
|
Filippo Petti
Chief Executive Officer and
Financial Officer
|
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Celyad Oncology (NASDAQ:CYAD)
Historical Stock Chart
From Mar 2023 to Mar 2024